{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T08:36:57Z","timestamp":1782203817045,"version":"3.54.5"},"reference-count":36,"publisher":"Sociedade Brasileira de Cardiologia","issue":"6","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arq. Bras. Cardiol."],"abstract":"<jats:p>Resumo  Fundamento  A insufici\u00eancia card\u00edaca (IC) \u00e9 uma das principais causas de morbidade e mortalidade no mundo. Poucos estudos avaliaram a sobrevida e fatores progn\u00f3sticos de pacientes com esta condi\u00e7\u00e3o frente aos avan\u00e7os terap\u00eauticos das \u00faltimas d\u00e9cadas.  Objetivos  Descrever a sobrevida, poss\u00edveis fatores associados a mortalidade e caracter\u00edsticas cl\u00ednicas dos participantes com IC do Estudo Longitudinal de Sa\u00fade do Adulto (ELSA-Brasil).  M\u00e9todos  A coorte acompanhou 15.105 participantes, entre 2008 e 2023. Foram avaliadas vari\u00e1veis sociodemogr\u00e1ficas, exames laboratoriais, eletrocardiograma, ecocardiograma bidimensional, h\u00e1bitos de vida, comorbidades e tratamento medicamentoso. A probabilidade de sobrevida foi estimada atrav\u00e9s das curvas de Kaplan-Meier e testes de log-rank. Modelagem de regress\u00e3o de Cox, permitiu calcular as Hazard Ratios (HR), brutas e ajustadas, com seus respectivos intervalos de confian\u00e7a de 95%. Utilizou-se o crit\u00e9rio de signific\u00e2ncia p&lt;0,05.  Resultados  Durante a etapa de inclus\u00e3o, foram selecionados 251 participantes com diagn\u00f3stico de IC (2008-2010). No per\u00edodo aproximado de 12,3 anos de acompanhamento, 48(19%) faleceram. A sobrevida global dos participantes com IC nos 2, 6, 10 e 12,3 anos de seguimento, foi de 96%, 89%, 82% e 80% respectivamente. O risco de mortalidade foi 4,5 vezes maior (HR:4,46; IC95%: 3,3\u20135,9) em compara\u00e7\u00e3o com o grupo n\u00e3o acometido, (p&lt;0,01) e mesmo ap\u00f3s a aplica\u00e7\u00e3o de modelo ajustado, o risco de mortalidade permaneceu duas vezes mais elevado, (HR:1,77; IC95%:1,3\u20132,4). As vari\u00e1veis associadas a pior progn\u00f3stico foram: sexo masculino, idade avan\u00e7ada, disfun\u00e7\u00e3o sist\u00f3lica (FEVE&lt;45%), hipertens\u00e3o arterial, diabetes mellitus e doen\u00e7a renal cr\u00f4nica.  Conclus\u00e3o  Encontramos elevada mortalidade em participantes com IC na coorte ELSA-Brasil.<\/jats:p>","DOI":"10.36660\/abc.20240705","type":"journal-article","created":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T11:19:38Z","timestamp":1749208778000},"source":"Crossref","is-referenced-by-count":1,"title":["An\u00e1lise de Sobrevida e Fatores Associados a Mortalidade em Portadores de Insufici\u00eancia Card\u00edaca na Coorte ELSA-Brasil"],"prefix":"10.36660","volume":"122","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7846-4989","authenticated-orcid":false,"given":"Ana Paula de Oliveira","family":"L\u00e9do","sequence":"first","affiliation":[{"name":"Universidade Federal da Bahia,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheila Maria Alvim","family":"Matos","sequence":"additional","affiliation":[{"name":"Universidade Federal da Bahia,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria da Concei\u00e7\u00e3o","family":"Almeida","sequence":"additional","affiliation":[{"name":"Funda\u00e7\u00e3o Oswaldo Cruz,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3755-3659","authenticated-orcid":false,"given":"Luciana Pereira","family":"Fernandes","sequence":"additional","affiliation":[{"name":"Universidade Federal da Bahia,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2161-3696","authenticated-orcid":false,"given":"Roque","family":"Aras","sequence":"additional","affiliation":[{"name":"Universidade Federal da Bahia,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"22636","published-online":{"date-parts":[[2025]]},"reference":[{"issue":"18","key":"ref1","first-page":"e876","article-title":"2022 AHA\/ACC\/HFSA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"145","author":"Heidenreich PA","year":"2022","journal-title":"Circulation"},{"issue":"6","key":"ref2","first-page":"1174","article-title":"Emerging Topics Update of the Brazilian Heart Failure Guideline - 2021","volume":"116","author":"Marcondes-Braga FG","year":"2021","journal-title":"Arq Bras Cardiol"},{"issue":"3","key":"ref3","first-page":"436","article-title":"Diretriz Brasileira de Insufici\u00eancia Card\u00edaca Cr\u00f4nica e Aguda","volume":"111","author":"Rohde LEP","year":"2018","journal-title":"Arq Bras Cardiol"},{"issue":"1","key":"ref4","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1080\/20009666.2016.1264696","article-title":"Prevalence and Risk Factors of Heart Failure in the USA: NHANES 2013 - 2014 Epidemiological Follow-Up Study","volume":"7","author":"Komanduri S","year":"2017","journal-title":"J Community Hosp Intern Med Perspect"},{"issue":"7","key":"ref5","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S2214-109X(17)30196-1","article-title":"Global Mortality Variations in Patients with Heart Failure: Results from the International Congestive Heart Failure (INTER-CHF) Prospective Cohort Study","volume":"5","author":"Dokainish H","year":"2017","journal-title":"Lancet Glob Health"},{"issue":"18","key":"ref6","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1016\/j.ehj.2004.06.038","article-title":"Quantifying the Heart Failure Epidemic: Prevalence, Incidence Rate, Lifetime Risk and Prognosis of Heart Failure the Rotterdam Study","volume":"25","author":"Bleumink GS","year":"2004","journal-title":"Eur Heart J"},{"issue":"8","key":"ref7","article-title":"Use of the ADHERE Risk Model as a Predictor of Risk of in-Hospital Worsening Heart Failure in a Cohort","volume":"120","author":"Bernardes DS","year":"2023","journal-title":"Arq Bras Cardiol"},{"issue":"11","key":"ref8","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1002\/ejhf.1594","article-title":"Survival of Patients with Chronic Heart Failure in the Community: A Systematic Review and Meta-Analysis","volume":"21","author":"Jones NR","year":"2019","journal-title":"Eur J Heart Fail"},{"issue":"27","key":"ref9","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","article-title":"2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure of the European Society of Cardiology (ESC) Developed with the Special Contribution of the Heart Failure Association (HFA) of the ESC","volume":"37","author":"Ponikowski P","year":"2016","journal-title":"Eur Heart J"},{"issue":"2","key":"ref10","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s10741-021-10105-w","article-title":"Biomarkers for the Diagnosis and Management of Heart Failure","volume":"27","author":"Castiglione V","year":"2022","journal-title":"Heart Fail Rev"},{"issue":"2","key":"ref11","first-page":"359","article-title":"The Challenges of Heart Failure Yesterday, Today and Tomorrow and the 20 Years of DEIC","volume":"116","author":"Mesquita ET","year":"2021","journal-title":"Arq Bras Cardiol"},{"key":"ref12","article-title":"Trends in Mortality from Heart Failure in Brazil: 1998 to 2019","volume":"25","author":"Arruda VL","year":"2022","journal-title":"Rev Bras Epidemiol"},{"issue":"1","key":"ref13","first-page":"29","article-title":"The Economic Burden of Heart Conditions in Brazil","volume":"111","author":"Stevens B","year":"2018","journal-title":"Arq Bras Cardiol"},{"issue":"4","key":"ref14","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1093\/aje\/kwr294","article-title":"Brazilian Longitudinal Study of Adult Health (ELSA-Brasil): Objectives and Design","volume":"175","author":"Aquino EM","year":"2012","journal-title":"Am J Epidemiol"},{"issue":"1","key":"ref15","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1093\/ije\/dyu027","article-title":"Cohort Profile: Longitudinal Study of Adult Health (ELSA-Brasil)","volume":"44","author":"Schmidt MI","year":"2015","journal-title":"Int J Epidemiol"},{"key":"ref16","first-page":"10","article-title":"Participants Recruitment in ELSA-Brasil (Brazilian Longitudinal Study for Adult Health)","volume":"47","author":"Aquino EM","year":"2013","journal-title":"Rev Saude Publica"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1590\/S0034-8910.2013047003889","article-title":"Strategies and Development of Quality Assurance and Control in the ELSA-Brasil","volume":"47","author":"Schmidt MI","year":"2013","journal-title":"Rev Saude Publica"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1590\/S0034-8910.2013047003807","article-title":"Logistics of Collection and Transportation of Biological Samples and the Organization of the Central Laboratory in the ELSA-Brasil","volume":"47","author":"Fedeli LG","year":"2013","journal-title":"Rev Saude Publica"},{"key":"ref19","first-page":"54","article-title":"Medical Assessments and Measurements in ELSA-Brasil","volume":"47","author":"Mill JG","year":"2013","journal-title":"Rev Saude Publica"},{"key":"ref20","first-page":"87","article-title":"Challenges to Implementation of the ECG Reading Center in ELSA-Brasil","volume":"47","author":"Ribeiro ALP","year":"2013","journal-title":"Rev Saude Publica"},{"issue":"5","key":"ref21","first-page":"916","article-title":"Simple Echocardiographic Parameters are Strong Predictors of the Cardiovascular Risk in Asymptomatic Individuals: Elsa-Brasil Cohort","volume":"118","author":"Fernandes LP","year":"2022","journal-title":"Arq Bras Cardiol"},{"issue":"1","key":"ref22","first-page":"36","article-title":"Leisure-Time Physical Activity, but not Commuting Physical Activity, is Associated with Cardiovascular Risk among ELSA-Brasil Participants","volume":"110","author":"Pitanga FJG","year":"2018","journal-title":"Arq Bras Cardiol"},{"issue":"1","key":"ref23","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/00005650-198601000-00007","article-title":"Concurrent and Predictive Validity of a Self-Reported Measure of Medication Adherence","volume":"24","author":"Morisky DE","year":"1986","journal-title":"Med Care"},{"issue":"25 Pt B","key":"ref24","first-page":"2935","article-title":"2013 ACC\/AHA Guideline on the Assessment of Cardiovascular Risk: A Report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"63","author":"Goff Jr DC","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"ref25","first-page":"79","article-title":"ELSA-Brasil Strategies for Outcome Identification, Investigation and Ascertainment","volume":"47","author":"Barreto SM","year":"2013","journal-title":"Rev Saude Publica"},{"issue":"4","key":"ref26","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1161\/CIRCULATIONAHA.108.812172","article-title":"Long-Term Trends in First Hospitalization for Heart Failure and Subsequent Survival between 1986 and 2003: A Population Study of 5.1 Million People","volume":"119","author":"Jhund PS","year":"2009","journal-title":"Circulation"},{"issue":"2","key":"ref27","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.ahj.2007.08.036","article-title":"Life Expectancy after an Index Hospitalization for Patients with Heart Failure: A Population-Based Study","volume":"155","author":"Ko DT","year":"2008","journal-title":"Am Heart J"},{"issue":"7","key":"ref28","doi-asserted-by":"crossref","DOI":"10.5867\/medwave.2021.07.8440","article-title":"Survival Analysis of Patients with Heart Failure in the Ecuadorian Andean population","volume":"21","author":"Gudi\u00f1o-Gomezjurado AF","year":"2021","journal-title":"Medwave"},{"issue":"10","key":"ref29","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1016\/j.cardfail.2023.07.006","article-title":"Heart Failure Epidemiology and Outcomes Statistics: A Report of the Heart Failure Society of America","volume":"29","author":"Bozkurt B","year":"2023","journal-title":"J Card Fail"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"l223","DOI":"10.1136\/bmj.l223","article-title":"Trends in Survival after a Diagnosis of Heart Failure in the United Kingdom 2000-2017: Population based Cohort Study","volume":"364","author":"Taylor CJ","year":"2019","journal-title":"BMJ"},{"issue":"25","key":"ref31","first-page":"2589","article-title":"Race and Ethnicity in Heart Failure: JACC Focus Seminar 8\/9","volume":"78","author":"Pi\u00f1a IL","year":"2021","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"ref32","doi-asserted-by":"crossref","first-page":"4444","DOI":"10.1002\/ehf2.13646","article-title":"'Time is Prognosis' in Heart Failure: Time-to-Treatment Initiation as a Modifiable Risk Factor","volume":"8","author":"Abdin A","year":"2021","journal-title":"ESC Heart Fail"},{"issue":"5","key":"ref33","doi-asserted-by":"crossref","first-page":"727","DOI":"10.4070\/kcj.2017.0050","article-title":"Relation of Renal Function with Left Ventricular Systolic Function and NT-proBNP Level and Its Prognostic Implication in Heart Failure with Preserved versus Reduced Ejection Fraction: An Analysis from the Korean Heart Failure (KorHF) Registry","volume":"47","author":"Park CS","year":"2017","journal-title":"Korean Circ J"},{"issue":"9","key":"ref34","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1093\/eurheartj\/ehm102","article-title":"Prognosis of All-Cause Heart Failure and Borderline Left Ventricular Systolic Dysfunction: 5 Year Mortality Follow-Up of the Echocardiographic Heart of England Screening Study (ECHOES)","volume":"28","author":"Hobbs FD","year":"2007","journal-title":"Eur Heart J"},{"issue":"2","key":"ref35","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s10741-018-9757-1","article-title":"Practical Guidance on the Use of Sacubitril\/Valsartan for Heart Failure","volume":"24","author":"Sauer AJ","year":"2019","journal-title":"Heart Fail Rev"},{"issue":"2","key":"ref36","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.cardfail.2015.10.017","article-title":"The Prevalence of Stages of Heart Failure in Primary Care: A Population-Based Study","volume":"22","author":"Jorge AL","year":"2016","journal-title":"J Card Fail"}],"container-title":["Arquivos Brasileiros de Cardiologia"],"original-title":["Survival Analysis and Factors Associated with Mortality in Heart Failure Patients in the ELSA-Brasil Cohort"],"link":[{"URL":"https:\/\/abccardiol.org\/wp-content\/uploads\/articles_xml\/0066-782x-abc-122-6-e20240705\/0066-782x-abc-122-6-e20240705.x95083.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T11:19:44Z","timestamp":1749208784000},"score":1,"resource":{"primary":{"URL":"https:\/\/abccardiol.org\/article\/analise-de-sobrevida-e-fatores-associados-a-mortalidade-em-portadores-de-insuficiencia-cardiaca-na-coorte-elsa-brasil\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":36,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025]]}},"alternative-id":["S0066-782X2025000600304"],"URL":"https:\/\/doi.org\/10.36660\/abc.20240705","relation":{"is-translation-of":[{"id-type":"doi","id":"10.36660\/abc.20240705i","asserted-by":"subject"},{"id-type":"doi","id":"10.36660\/abc.20240705i","asserted-by":"object"}]},"ISSN":["1678-4170","0066-782X"],"issn-type":[{"value":"1678-4170","type":"electronic"},{"value":"0066-782X","type":"print"}],"subject":[],"published":{"date-parts":[[2025]]},"article-number":"e20240705"}}